Proliferation and motility of HaCaT keratinocyte derivatives is enhanced by fibroblast nemosis

Experimental Cell Research

Volumn 316, Issue 10, 2010, Pages 1739-1747

  Räsänen, Kati ^a   Vaheri, Antti ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Fibroblast; Keratinocyte; Microenvironment; Nemosis; Paracrine regulation; Tumorigenesis

Indexed keywords

GROWTH FACTOR; KI 67 ANTIGEN; NEUTRALIZING ANTIBODY; TUMOR MARKER;

ARTICLE; BENIGN TUMOR; CANCER INVASION; CANCER STEM CELL; CELL FUNCTION; CELL MOTILITY; CELL PROLIFERATION; CELL STRAIN; CELL STRAIN HACAT; CONTROLLED STUDY; CULTURE MEDIUM; FIBROBLAST; HUMAN; HUMAN CELL; KERATINOCYTE; MALIGNANT NEOPLASTIC DISEASE; NEMOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCRATCHING; SKIN CARCINOGENESIS; SKIN CARCINOMA; SPHEROID CELL; WOUND HEALING IMPAIRMENT;

EID: 77953229585     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2010.01.020     Document Type: Article

References (50)

1. Werner S., Krieg T., Smola H. Keratinocyte-Fibroblast interactions in wound healing. J. Invest. Dermatol. 2007, 127:998-1008.
2. Santoro M.M., Gaudino G. Cellular and molecular facets of keratinocyte reepithelization during wound healing. Exp. Cell Res. 2005, 304:274-286.
3. Ingber D.E. Cancer as a disease of epithelial-mesenchymal interactions and extracellular matrix regulation. Differentiation 2002, 70:547-560.
4. Fusenig N.E., Boukamp P. Multiple stages and genetic alterations in immortalization, malignant transformation, and tumor progression of human skin keratinocytes. Mol. Carcinog. 1998, 23:144-158.
5. Mueller M.M., Fusenig N.E. Tumor-Stroma interactions directing phenotype and progression of epithelial skin tumor cells. Differentiation 2002, 70:486-497.
6. Kalluri R., Zeisberg M. Fibroblasts in cancer. Nat. Rev. Cancer 2006, 6:392-401.
7. Vaheri A., Enzerink A., Rasanen K., Salmenpera P. Nemosis, a novel way of fibroblast activation, in inflammation and cancer. Exp. Cell Res. 2009, 315:1633-1638.
8. Kankuri E., Cholujova D., Comajova M., Vaheri A., Bizik J. Induction of hepatocyte growth factor/scatter factor by fibroblast clustering directly promotes tumor cell invasiveness. Cancer Res. 2005, 65:9914-9922.
9. Räsänen K., Salmenperä P., Baumann M., Virtanen I., Vaheri A. Nemosis of fibroblasts is inhibited by benign HaCaT keratinocytes but promoted by malignant HaCaT cells. Mol. Oncol. 2008, 2:340-348.
10. Rasanen K., Virtanen I., Salmenpera P., Grenman R., Vaheri A. Differences in the nemosis response of normal and cancer-associated fibroblasts from patients with oral squamous cell carcinoma. PLoS One 2009, 4:e6879.
11. Peura M., Bizik J., Salmenpera P., Noro A., Korhonen M., Patila T., Vento A., Vaheri A., Alitalo R., Vuola J., Harjula A., Kankuri E. Bone marrow mesenchymal stem cells undergo nemosis and induce keratinocyte wound healing utilizing the HGF/c-Met/PI3K pathway. Wound Repair Regen. 2009, 17:569-577.
12. Delehedde M., Lyon M., Vidyasagar R., McDonnell T.J., Fernig D.G. Hepatocyte growth factor/scatter factor binds to small heparin-derived oligosaccharides and stimulates the proliferation of human HaCaT keratinocytes. J. Biol. Chem. 2002, 277:12456-12462.
13. Furuya M., Yonemitsu Y. Cancer neovascularization and proinflammatory microenvironments. Curr. Cancer Drug Targets 2008, 8:253-265.
14. Barrientos S., Stojadinovic O., Golinko M.S., Brem H., Tomic-Canic M. Growth factors and cytokines in wound healing. Wound Repair Regen. 2008, 16:585-601.
15. Pierce G.F., Yanagihara D., Klopchin K., Danilenko D.M., Hsu E., Kenney W.C., Morris C.F. Stimulation of all epithelial elements during skin regeneration by keratinocyte growth factor. J. Exp. Med. 1994, 179:831-840.
16. Pellegrini G., Dellambra E., Golisano O., Martinelli E., Fantozzi I., Bondanza S., Ponzin D., McKeon F., De Luca M. P63 identifies keratinocyte stem cells. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:3156-3161.
17. Koster M.I., Kim S., Mills A.A., DeMayo F.J., Roop D.R. P63 is the molecular switch for initiation of an epithelial stratification program. Genes Dev. 2004, 18:126-131.
18. Di Como C.J., Urist M.J., Babayan I., Drobnjak M., Hedvat C.V., Teruya-Feldstein J., Pohar K., Hoos A., Cordon-Cardo C. P63 expression profiles in human normal and tumor tissues. Clin. Cancer Res. 2002, 8:494-501.
19. Westfall M.D., Pietenpol J.A. p63: molecular complexity in development and cancer. Carcinogenesis 2004, 25:857-864.
20. Jung S.M., Lin H.C., Chu P.H., Wu H.H., Shiu T.F., Huang S.L., Lai C.H. Expression of cell cycle-regulatory proteins, MIB-1, p16, p53, and p63, in squamous cell carcinoma of conjunctiva: Not associated with human papillomavirus infection. Virchows Arch. 2006, 448:301-305.
21. Vered M., Allon I., Dayan D. Maspin, p53, p63, and ki-67 in epithelial lesions of the tongue: from hyperplasia through dysplasia to carcinoma. J. Oral Pathol. Med. 2009, 38:314-320.
22. Mueller M.M., Fusenig N.E. Constitutive expression of G-CSF and GM-CSF in human skin carcinoma cells with functional consequence for tumor progression. Int. J. Cancer 1999, 83:780-789.
23. Geback T., Schulz M.M., Koumoutsakos P., Detmar M. TScratch: a novel and simple software tool for automated analysis of monolayer wound healing assays. BioTechniques 2009, 46:265-274.
24. Senoo M., Pinto F., Crum C.P., McKeon F. p63 is essential for the proliferative potential of stem cells in stratified epithelia. Cell 2007, 129:523-536.
25. van Diest P.J., Brugal G., Baak J.P. Proliferation markers in tumours: interpretation and clinical value. J. Clin. Pathol. 1998, 51:716-724.
26. Quaranta V. Motility cues in the tumor microenvironment. Differentiation 2002, 70:590-598.
27. Salmenpera P., Kankuri E., Bizik J., Siren V., Virtanen I., Takahashi S., Leiss M., Fassler R., Vaheri A. Formation and activation of fibroblast spheroids depend on fibronectin-integrin interaction. Exp. Cell Res. 2008, 314:3444-3452.
28. Kankuri E., Babusikova O., Hlubinova K., Salmenpera P., Boccaccio C., Lubitz W., Harjula A., Bizik J. Fibroblast nemosis arrests growth and induces differentiation of human leukemia cells. Int. J. Cancer 2008, 122:1243-1252.
29. Enzerink A., Salmenpera P., Kankuri E., Vaheri A. Clustering of fibroblasts induces proinflammatory chemokine secretion promoting leukocyte migration. Mol. Immunol. 2009, 46:1787-1795.
30. A. Enzerink, V. Rantanen, A. Vaheri, Fibroblast nemosis induces angiogenic responses of endothelial cells, Exp. Cell Res. 316 (2010) 826--835.
31. Pich A., Chiusa L., Navone R. Prognostic relevance of cell proliferation in head and neck tumors. Ann. Oncol. 2004, 15:1319-1329.
32. Suomela S., Elomaa O., Skoog T., Ala-aho R., Jeskanen L., Parssinen J., Latonen L., Grenman R., Kere J., Kahari V.M., Saarialho-Kere U. CCHCR1 is up-regulated in skin cancer and associated with EGFR expression. PLoS One 2009, 4:e6030.
33. Keyes W.M., Mills A.A. P63: a new link between senescence and aging. Cell Cycle 2006, 5:260-265.
34. Tomkova K., Tomka M., Zajac V. Contribution of p53, p63, and p73 to the developmental diseases and cancer. Neoplasma 2008, 55:177-181.
35. Ambler C.A., Maatta A. Epidermal stem cells: location, potential and contribution to cancer. J. Pathol. 2009, 217:206-216.
36. Rubin J.S., Bottaro D.P., Chedid M., Miki T., Ron D., Cheon G., Taylor W.G., Fortney E., Sakata H., Finch P.W. Keratinocyte growth factor. Cell Biol. Int. 1995, 19:399-411.
37. Cao Y., Liu Q. Therapeutic targets of multiple angiogenic factors for the treatment of cancer and metastasis. Adv. Cancer Res. 2007, 97:203-224.
38. Ferretti C., Bruni L., Dangles-Marie V., Pecking A.P., Bellet D. Molecular circuits shared by placental and cancer cells, and their implications in the proliferative, invasive and migratory capacities of trophoblasts. Hum. Reprod. Updat. 2007, 13:121-141.
39. Breitkreutz D., Boukamp P., Ryle C.M., Stark H.J., Roop D.R., Fusenig N.E. Epidermal morphogenesis and keratin expression in c-ha-ras-transfected tumorigenic clones of the human HaCaT cell line. Cancer Res. 1991, 51:4402-4409.
40. Gao C.F., Vande Woude G.F. HGF/SF-met signaling in tumor progression. Cell Res. 2005, 15:49-51.
41. Kranenburg O., Gebbink M.F., Voest E.E. Stimulation of angiogenesis by ras proteins. Biochim. Biophys. Acta 2004, 1654:23-37.
42. Ranzato E., Patrone M., Mazzucco L., Burlando B. Platelet lysate stimulates wound repair of HaCaT keratinocytes. Br. J. Dermatol. 2008, 159:537-545.
43. Kovacs D., Cardinali G., Aspite N., Picardo M. Bovine colostrum promotes growth and migration of the human keratinocyte HaCaT cell line. Growth Factors 2009, 1.
44. Siren V., Salmenpera P., Kankuri E., Bizik J., Sorsa T., Tervahartiala T., Vaheri A. Cell-Cell contact activation of fibroblasts increases the expression of matrix metalloproteinases. Ann. Med. 2006, 38:212-220.
45. MacDougall J.R., Matrisian L.M. Contributions of tumor and stromal matrix metalloproteinases to tumor progression, invasion and metastasis. Cancer Metastasis Rev. 1995, 14:351-362.
46. Egeblad M., Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer 2002, 2:161-174.
47. Vosseler S., Lederle W., Airola K., Obermueller E., Fusenig N.E., Mueller M.M. Distinct progression-associated expression of tumor and stromal MMPs in HaCaT skin SCCs correlates with onset of invasion. Int. J. Cancer 2009, 125:2296-2306.
48. Laeeq S., Faust R. Modeling the cholesteatoma microenvironment: coculture of HaCaT keratinocytes with WS1 fibroblasts induces MMP-2 activation, invasive phenotype, and proteolysis of the extracellular matrix. Laryngoscope 2007, 117:313-318.
49. Bachmeier B.E., Boukamp P., Lichtinghagen R., Fusenig N.E., Fink E. Matrix metalloproteinases-2, -3, -7, -9 and -10, but not MMP-11, are differentially expressed in normal, benign tumorigenic and malignant human keratinocyte cell lines. Biol. Chem. 2000, 381:497-507.
50. Poincloux R., Lizarraga F., Chavrier P. Matrix invasion by tumour cells: a focus on MT1-MMP trafficking to invadopodia. J. Cell. Sci. 2009, 122:3015-3024.